Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier

Journal of Infectious Diseases

Volumn 185, Issue 7, 2002, Pages 950-962

  Chernyak, Anatoly ^a   Kondo, Seiichi ^c   Wade, Terri K ^b   Meeks, Michael D ^b   Alzari, Pedro M ^d   Fournier, Jean Michel ^e   Taylor, Ronald K ^b   Kováč, Pavol ^a   Wade, William F ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c JOSAI UNIVERSITY   (Japan)

^d CNRS   (France)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; BOVINE SERUM ALBUMIN; CARBOHYDRATE; CARRIER PROTEIN;

AGED; ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; SEROTYPE; VIBRIO CHOLERAE;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; CHOLERA; CHOLERA VACCINES; EPITOPES, T-LYMPHOCYTE; FEMALE; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; O ANTIGENS; SERUM ALBUMIN, BOVINE; T-LYMPHOCYTES; VACCINATION; VACCINES, CONJUGATE; VIBRIO CHOLERAE;

EID: 0036534815     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/339583     Document Type: Article

References (47)

1. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin
2. Immune mechanisms and protection antigens of Vibrio cholerae serogroup O139 as a basis for vaccine development
3. Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: Specificity and relevance to immunity
4. Lipopolysaccharide- and cholera toxin-specific subclass distribution of B-cell responses in cholera
5. The role of immunity in cholera: A review of epidemiological and serological studies
6. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid
7. New model for analysis of mucosal immunity: Intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection
8. Occurrence of 2-O-methyl-N-(3-deoxy-L-glycero-tetronyl)-D-perosamine(4-amino-4,6- dideoxy-D-manno-pyrranose) in lipopolysaccharide from Ogawa but not from Inaba O forms of O1 Vibrio cholerae
9. On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba
10. Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1
11. Crystal structure of an anticarbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: Molecular basis for serotype specificity
12. Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induced protective immunity against LVS infection that requires B cells and gamma interferon
13. Protection against fatal Pseudomonas aeruginosa burn wound sepsis by immunization with lipopolysaccharide and high-molecular-weight polysaccharide
14. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity
15. Vibrio cholerae O139 conjugate vaccines: Synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice
16. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid
17. Polysaccharide vaccines as probes of antibody repertoires in man
18. Structural studies of the Vibrio cholerae O-antigen
19. Identification of a novel sugar, 4-amino-4,6-dideoxy-2-O-methyl-mannose in the lipopolysaccharide of Vibrio cholerae O1 serotype Ogawa
20. Immunogenicity in infants of Haemophilus influenzae type B polysaccharide in a conjugate vaccine with Neisseria meningitidis outer-membrane protein
21. Synthetic polysaccharide type 3-related di-, tri-, and tetrasaccharide-CRM(197) conjugates induce protection against Streptococcus pneumoniae type 3 in mice
22. Synthesis of ligands related to the Vibrio cholerae O-specific antigen. Part 12. Synthesis of eight glycosides of hexasaccharide fragments representing the terminus of the O-polysaccharide of Vibrio cholerae O:1, serotype Inaba and Ogawa, bearing aglycons suitable for linking to proteins
23. Conjugating oligosaccharides to proteins by squaric acid diester chemistry: Rapid monitoring of the progress of conjugation, and recovery of the unused ligand
24. Conjugation of p-aminophenyl glycosides with squaric acid diester to a carrier protein and the use of neoglycoprotein in the histochemical detection of lectins
25. Studies on vaccines against cholera: Synthesis of neoglycoconjugates from the hexasaccharide determinant of Vibrio cholerae O:1, serotype Ogawa, by single-point attachment or by attachment of the hapten in the form of clusters
26. Synthesis of ligands related to the Vibrio cholerae O-specific antigen. Part 11. Synthesis of four glycosides of a disaccharide fragment representing the terminus of the O-polysaccharide of Vibrio cholerae O:1, serotype Inaba, bearing aglycons suitable for linking to proteins
27. An alternative method for the selective reduction of unsaturated nucleoside azides to the amines
28. Synthesis of antigenic determinants of the Brucella A antigen, utilizing methyl 4-azido-4,6-dideoxy-alpha-D-mannopyranoside efficiently derived from D-mannose
29. An improved synthesis of D-perosamine and some derivatives
30. New N-acylation reagents derived from 3-deoxy-L-glycero-tetronic acid
31. Identification of N-3-hydroxypropionyl-2-O-methyl-D-perosamine as a specific constituent of the lipopolysaccharide from Vibrio cholerae - Serogroup 1875 which has Ogawa antigen factor B of Vibrio cholerae O1
32. Delineation of pilin domains required for bacterial association into microcolonies and intestinal colonization by Vibrio cholerae
33. Vibriocidal antibody inhibition (VAI) analysis: A technique for the identification of the predominant vibriocidal antibodies in serum and for the detection and identification of Vibrio cholerae antigens
34. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model
35. H7183 gene family in BALB/c mice
36. H7183 gene family is not due to recombination signal sequence variation, and mapping of the genes shows a bias of rearrangement based on chromosomal location
37. Protective activities of serum immunoglobulin G on the mucosal surface to Vibrio cholerae O1
38. Vibrio cholerae intestinal population dynamics in the suckling mouse model of infection
39. Immunogenicity of a Haemophilus influenzae polysaccharide - Neisseria meningitidis outer membrane protein complex conjugate vaccine
40. Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1
41. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay
42. Protective efficacy of IgM monoclonal antibodies in experimental group B streptococcal infection is a function of antibody avidity
43. Non-ionic block polymer surfactants enhance the avidity of antibodies in polyclonal antisera against Streptococcus pneumoniae type 3 in normal and Xid mice
44. Immunons revisited: Binding of multivalent antigens to B cells
45. Complex serology and immune response of mice to variant high-molecular-weight O polysaccharides isolated from Pseudomonas aeruginosa serogroup O2 strains
46. Properties determining the potential of naturally occurring and vaccine-induced human antibodies to protect against lethal infection of Pseudomonas aeruginosa
47. Somatic hypermutation in T-independent and T-dependent immune responses to Haemophilus influenzae type b polysaccharide